Riskpilot← Back to searchSign inGet full accessCARDIOCARE SCANDINAVIA ApS
APSActiveCVR 34581800Fabrikvej 11BActivities of agents involved in non-specialised wholesale · NACE 4619Est. 20127 employeeswww.cardiocare.dk
Revenue 2024
DKK 4,2M
+39% vs 2023
EBITDA margin
15.0%
+303% vs 2023
Equity ratio
29.7%
Financial strength
Net profit 2024
DKK 398K
+9821% vs 2023
| Revenue | DKK 4,2M | +39% |
| EBITDA | DKK 639K | +303% |
| Net profit | DKK 398K | +9821% |
| Total assets | DKK 3,4M | +1% |
| Equity | DKK 1.000K | +66% |
| Employees | 7 | — |
Legal name
CARDIOCARE SCANDINAVIA ApS
CVR number
34581800
Legal form
Anpartsselskab
NACE code
4619 · Activities of agents involved in non-specialised wholesale
Founded
24. maj 2012
Share capital
DKK 80.000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive handelsvirksomhed.
Address
Fabrikvej 11B
Phone
+4586284900
Email
lmp@cardiocare.dk
Website
www.cardiocare.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1.981 | 2.546 | 3.288 | 3.047 | 4.245 |
| Staff expenses | -2.691 | -2.130 | -2.684 | -2.889 | -3.606 |
| EBITDA | -710 | 416 | 604 | 158 | 639 |
| Depreciation & amort. | -111 | -157 | -120 | -19 | -50 |
| EBIT | -821 | 259 | 484 | 139 | 589 |
| Net financials | 2 | -9 | -55 | -121 | -75 |
| Profit before tax | -820 | 250 | 429 | 18 | 514 |
| Tax | -179 | 58 | 97 | 22 | 116 |
| Net profit | -641 | 192 | 333 | -4 | 398 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2.652 | 3.570 | 3.044 | 3.341 | 3.372 |
| Equity | 81 | 274 | 606 | 602 | 1.000 |
| Long-term debt | 6 | 6 | 6 | 7 | 7 |
| Short-term debt | 2.564 | 3.290 | 2.431 | 2.732 | 2.365 |
| Total debt | 2.570 | 3.296 | 2.437 | 2.739 | 2.372 |
EBITDA margin
15.0%
This company
15.8%
Market median
-5% vs market
20202024
Equity ratio
29.7%
This company
38.2%
Market median
-22% vs market
20202024
Return on equity
39.8%
This company
18.4%
Market median
+116% vs market
20202024
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20202024
Asset turnover
1.26×
This company
1.12×
Market median
+12% vs market
20202024
Debt / equity
2.37×
This company
0.62×
Market median
-282% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PM Management | Management | 2025 |
| Former (4) | ||
JB Management | Management | 2012 – 2014 |
LM Management | Management | 2015 – 2017 |
KM Chief Executive Officer | Chief Executive Officer | 2014 – 2015 |
BP Management | Management | 2015 – 2025 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2012 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MATRIC HOLDING ApS
CARDIOCARE SCANDINAVIA ApS Board members of CARDIOCARE SCANDINAVIA ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jørgen Bent Petersen | Management | 0 companies |
| Phillip Maron Petersen | Management | 0 companies |
| Lars Maron Petersen | Management | 0 companies |
| Karsten Maron | Chief Executive Officer | 0 companies |
| Birgitte Petersen | Management | 0 companies |